Clinical trials, hit by ransomware attack on health tech firm


The incidents come after more than a thousand ransomware attacks on American cities, counties and hospitals in the last 18 months. Once considered a nuisance by the attacks, in recent weeks American officials have worried that they could directly or indirectly interfere with the November election.

The first known death from cybertech in recent weeks resulted in a ransom vehicle attack in Germany, after Russian hackers seized 30 servers at the University Hospital Spiel D ડsseldorf, systems broke down and the hospital was forced to evacuate emergency patients. As a result, German authorities said, a woman in a critical condition was sent to a hospital 20 miles away in Wuppertal and died from a delay in treatment.

One of ERT’s clients, IQVIA, said it was able to limit the problems because it backed up its data. Bristol Myers Squibb also said the impact of the attack was limited, but other ERT clients had to move their clinical trials to get to the pen and paper.

In a statement, IQVA said the attack “had a limited impact on our clinical trial operations”, adding that “we have not compromised, compromised or stolen any confidential information or patient information related to our clinical trial activities.”

Pfizer and Johnson & Johnson, two companies working on the coronavirus vaccine, said their coronavirus vaccine tests had no effect.

Pfizer spokeswoman Amy Rose said the ERT Pfizer phase 1/2/3 Covid-19 vaccine is not a technical provider for clinical trials or otherwise.

Companies and research laboratories on the front lines of the epidemic have been repeat targets for foreign hackers over the past seven months, as countries around the world try to take into account each other’s reactions and progress in eradicating the virus. In May, the FBI and the Department of Homeland Security warned that Chinese government spies were actively trying to steal American clinical research through cybersheft.